Articles On Apiam Animal Health (ASX:AHX)

Investors are now backing Apiam to pursue a targeted growth-by-acquisition strategy as it scales up across regional Australia. For animal healthcare company Apiam (ASX:AHX), 2021 has gotten off to a cracking start as the company builds out...

If you want to know which ASX stocks fund managers and famous investors are putting their money into we’ve been keeping track of substantial holder buys (and sells). Trading Places is Stockhead’s recap of the substantial holder movements am...

Australia has one of the highest rates of household pet ownership in the world. The RSPCA estimates 61 per cent of Australian households own pets and all up there are over 29 million pets across the country. The most common domesticated an...

The Apiam Animal Health Ltd (ASX: AHX) share price is soaring today following the release of a positive Q1 update. The animal health company’s shares broke its share price record today, up 12% at a high of 70 cents at close of trade. The r...

An additional news report on the recommendation, valuation, forecast and opinion changes for ASX-listed equities. In addition to The Australian Broker Call Report, which is published and updated daily (Mon-Fri), FNArena has now added The Au...

Small caps Shaver Shop (ASX:SSG) and Apiam Animal Health (ASX:AHX)  reported strong profits for FY20 despite COVID-19. Shaver Shop’s profit after tax was $10.6 million – up 45 per cent from the prior corresponding period. This was from sale...

StockTalk is a Stockhead video series featuring a roundtable of experts discussing a new investment topic each week. In this edition, host Dr Nigel Finch discusses the ‘hidden gem’ animal health market. Populating the expert panel this week...

Nearly two years of pain for Factor Therapeutics (ASX:FTT) shareholders could be over soon with the company signing a term sheet to negotiate a potential acquisition. In 2018, Factor was trying to commercialise a wound-dressing drug, which...

While hand sanitiser demand took off thanks to COVID-19, there are also new markets emerging for products to protect animals. One small cap started with the pig industry, but is now eyeing the potentially lucrative horse racing industry. La...

In looking for opportunities in a heavily sold off market, Finfeed yesterday ran the ruler across five speculative stocks that were in sectors traditionally not for the risk averse. However, as we outlined, these companies have been support...

The property market looks to be heading north again after an 18-month slump, and McGrath’s (ASX:MEA) half-yearly results are reflecting the turnaround. After the property market slumped following a housing bubble between 2017 and 2018, the...

Zoono Group (ZNO) has released its quarterly report for the December quarter — which saw an almost-500 per cent bump in shares The strong quarter came off the back of the Zoono Z71 product which piqued the interest of a Chinese distributo...

New Zealand’s medicines regulator has recommended the country fall in line with Australia’s new codeine restrictions, and pharmaceutical companies are backing the decision. Yesterday, Medsafe recommended that all medications containing code...

Who needs human companionship when we have pets? They’re loyal, always happy to see you and won’t divorce you and take half your stuff. According to the RSPCA, Australia is home to 24 million domestic animals. Dogs were present in 38 per ce...

Australia’s S&P/ASX 200 (Index: ^AXJO)(ASX: XJO) and ALL ORDINARIES (Index: ^AXAO) (ASX: XAO) indices finished higher on Thursday. Here’s a short recap of the Australian market: S&P/ASX 200 (Index: ^AXJO) (ASX: XJO) higher 0.23%...

For a certain generation of investors the word ‘laser’ is indelibly tied to a Dr Evil reference. Over the last two years Invion (ASX:IVX) has been valiantly working against this association, and today says its lasers (not attached to the he...

An ex-football chairman and the CFO of an animal feed company walked into a bar the stock market and bought $100,000 worth of shares each in a pot stock. That might sound like a joke itself but last week it actually happened. Althea Group (...

Nearly 11 months on from its failed clinical trial and subsequent 97 per cent share price crash; Factor Therapeutics (ASX: FTT) has $3.1 million cash and a pipeline of opportunities but is yet to decide on one. Factor chairman Cherrell Hirs...

An additional news report on the recommendation, valuation, forecast and opinion changes for ASX-listed equities. In addition to The Australian Broker Call Report, which is published and updated daily (Mon-Fri), FNArena has now added The...

DroneShield (ASX:DRO) shares climbed as much as 12 per cent higher this morning after the company reported it made about $1.1m from selling drones. This is the third quarter in a row that DroneShield has increased its sales revenue. With go...

Stockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade. The market opens at 10am (eastern time) and the data is taken as at 10:15am, once every stock has commenced trading. Stocks highlighted in...

In this week’s recap of substantial holder movements four substantial holders bought shares in Zenith Energy (ASX:ZEN), a Shanghai investor bought into Anson Resources (ASX:ASN) and Sirtex’s founder bought into Syrah Resources (ASX:SYR). Su...